There’s been a lot of up and down around healthcare in the past year. 2011 doesn’t look any quieter. Or maybe it will for some companies. Approximately $25 billion worth of drugs are said to lose their patents in the coming year along with some very familiar household names such as Pfizer, Bristol-Myers, Lily’s and J&J losing over 93 million in familiar prescription names. This probably comes as no surprise considering the cost-saving efforts began from our declining economy in 2008.